Prognostic Value of Lymph Node Characteristics in Patients with Cervical Cancer Treated with Radical Hysterectomy

References

• Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18(8):1606–1613. doi:10.1200/JCO.2000.18.8.160610764420
   PubMed Web of Science ®Google Scholar
• Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study. Gynecol Oncol. 1999;73(2):177–183. doi:10.1006/gyno.1999.538710329031
   PubMed Web of Science ®Google Scholar
• Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol. 1990;38(3):352–357. doi:10.1016/0090-8258(90)90072-s2227547
   PubMed Web of Science ®Google Scholar
• Huang BX, Fang F. Progress in the study of lymph node metastasis in early-stage cervical cancer. Curr Med Sci. 2018;38(4):567–574. doi:10.1007/s11596-018-1915-030128863
   PubMed Web of Science ®Google Scholar
• Pieterse QD, Kenter GG, Gaarenstroom KN, et al. The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer. Eur J Surg Oncol. 2007;33(2):216–221. doi:10.1016/j.ejso.2006.09.03717097845
   PubMed Web of Science ®Google Scholar
• Ditto A, Martinelli F, Lo Vullo S, et al. The role of lymphadenectomy in cervical cancer patients: the significance of the number and the status of lymph nodes removed in 526 cases treated in a single institution. Ann Surg Oncol. 2013;20(12):3948–3954. doi:10.1245/s10434-013-3067-623812772
   PubMed Web of Science ®Google Scholar
• Lu H, Guo R, Yang H, et al. The prognostic value of negative lymph node count for patients with cervical cancer after radical surgery. Oncotarget. 2017;9(2):2810–2818. doi:10.18632/oncotarget.2359629416813
   PubMedGoogle Scholar
• Aoki Y, Sasaki M, Watanabe M, et al. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol. 2000;77(2):305–309. doi:10.1006/gyno.2000.578810785483
   PubMed Web of Science ®Google Scholar
• Joo JH, Kim YS, Nam JH. Prognostic significance of lymph node ratio in node-positive cervical cancer patients. Medicine. 2018;97(30):e11711. doi:10.1097/MD.000000000001171130045335
   PubMed Web of Science ®Google Scholar
• Aslan K, Meydanli MM, Oz M, Tohma YA, Haberal A, Ayhan A. The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy. J Gynecol Oncol. 2020;31(1):e1. doi:10.3802/jgo.2020.31.e131788991
   PubMed Web of Science ®Google Scholar
• Kim SI, Kim TH, Lee M, et al. Lymph node ratio is a strong prognostic factor in patients with early-stage cervical cancer undergoing minimally invasive radical hysterectomy. Yonsei Med J. 2021;62(3):231–239. doi:10.3349/ymj.2021.62.3.23133635013
   PubMed Web of Science ®Google Scholar
• Kehoe SM, Miller DS. The role of lymphadenectomy in endometrial cancer. Curr Treat Options Oncol. 2006;7(2):93–101. doi:10.1007/s11864-006-0044-316455020
   PubMedGoogle Scholar
• Lim S, Cho K, Lee S, et al. Effect of number of retrieved lymph nodes on prognosis in FIGO stage IB-IIA cervical cancer patients treated with primary radical surgery. J Obstet Gynaecol Res. 2017;43(1):211–219. doi:10.1111/jog.1317127862677
   PubMed Web of Science ®Google Scholar
• Lee YS, Chong GO, Lee YH, Hong DG, Cho YL, Park IS. Robot-assisted total preservation of the pelvic autonomic nerve with extended systematic lymphadenectomy as part of nerve-sparing radical hysterectomy for cervical cancer. Int J Gynecol Cancer. 2013;23(6):1133–1138. doi:10.1097/IGC.0b013e31829b10db23792607
   PubMed Web of Science ®Google Scholar
• Ramirez PT, Frumovitz M, Pareja R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379(20):1895–1904. doi:10.1056/NEJMoa180639530380365
   PubMed Web of Science ®Google Scholar
• Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–104. doi:10.1016/j.ijgo.2009.02.01219367689
   PubMed Web of Science ®Google Scholar
• Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncol. 2008;9(3):297–303. doi:10.1016/S1470-2045(08)70074-318308255
   PubMed Web of Science ®Google Scholar
• Kwon J, Eom KY, Kim YS, et al. The prognostic impact of the number of metastatic lymph nodes and a new prognostic scoring system for recurrence in early-stage cervical cancer with high risk factors: a multicenter cohort study (KROG 15-04). Cancer Res Treat. 2018;50(3):964–974. doi:10.4143/crt.2017.34629081219
   PubMed Web of Science ®Google Scholar
• Kenter GG, Hellebrekers BW, Zwinderman KH, van de Vijver M, Peters LA, Trimbos JB. The case for completing the lymphadenectomy when positive lymph nodes are found during radical hysterectomy for cervical carcinoma. Acta Obstet Gynecol Scand. 2000;79(1):72–76. doi:10.1034/j.1600-0412.2000.079001072.x10646820
   PubMed Web of Science ®Google Scholar
• Shah M, Lewin SN, Deutsch I, et al. Therapeutic role of lymphadenectomy for cervical cancer. Cancer. 2011;117(2):310–317. doi:10.1002/cncr.2540820862747
   PubMed Web of Science ®Google Scholar
• Mao S, Dong J, Li S, Wang Y, Wu P. Prognostic significance of number of nodes removed in patients with node-negative early cervical cancer. J Obstet Gynaecol Res. 2016;42(10):1317–1325. doi:10.1111/jog.1305827435888
   PubMed Web of Science ®Google Scholar
• Höckel M, Horn LC, Fritsch H. Association between the mesenchymal compartment of uterovaginal organogenesis and local tumour spread in stage IB-IIB cervical carcinoma: a prospective study. Lancet Oncol. 2005;6(10):751–756. doi:10.1016/S1470-2045(05)70324-716198980
   PubMed Web of Science ®Google Scholar
• Ungár L, Pálfalvi L, Tarnai L, Horányi D, Novák Z. Surgical treatment of lymph node metastases in stage IB cervical cancer. The laterally extended parametrectomy (LEP) procedure: experience with a 5 year follow-up. Gynecol Oncol. 2011;123(2):337–341. doi:10.1016/j.ygyno.2011.07.00121810536
   PubMed Web of Science ®Google Scholar
• Matsuura Y, Kawagoe T, Toki N, Tanaka M, Kashimura M. Long-standing complications after treatment for cancer of the uterine cervix–clinical significance of medical examination at 5 years after treatment. Int J Gynecol Cancer. 2006;16(1):294–297. doi:10.1111/j.1525-1438.2006.00354.x16445648
   PubMed Web of Science ®Google Scholar
• Wang L, Liu S, Xu T, Yuan L, Yang X. Sentinel lymph node mapping in early-stage cervical cancer: meta-analysis. Medicine. 2021;100(34):e27035. doi:10.1097/MD.000000000002703534449483
   PubMed Web of Science ®Google Scholar